Global Bioreactors Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 1,327.75 Million |
 Market Size (Forecast Year) |
USD 2,439.43 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球生物反应器市场，按产品类型（一次性、可重复使用）、细胞（哺乳动物细胞、细菌细胞、酵母细胞）、分子（单克隆抗体、疫苗、重组蛋白、干细胞、基因治疗）、用途（实验室规模生产、开发、临床前和临床、商业生产、中试规模生产和全面生产）、规模（5L-20L、20L-200L、200L-1500L 及 1500L 以上）、材料（玻璃、不锈钢和一次性）、控制类型（手动和自动）、供应商（OEM、系统集成商、EPC）、最终用户（研发部门、研发机构、CRO、生物制药公司、生物制药制造商和 CMO）– 行业趋势和预测到 2030 年。
生物反应器市场分析及规模
美国和加拿大是该地区最大的两个国家，在研发方面投入了大量资金。根据美国疾病控制和预防中心 (CDC) 的国家卫生统计中心 (NCHS) 的数据，美国在 2020 年在生物技术研究上花费了约 77.67 亿美元。他们还预测，到 2022 年，这一数字将上升到 79.12 亿美元。高额支出预计将推动市场增长，因为这意味着对生物反应器生产的新药和药物成分的需求增加。
Data Bridge Market Research 分析，生物反应器市场在 2022 年的规模为 13.2775 亿美元，预计到 2030 年将达到 24.3943 亿美元，在 2023 年至 2030 年的预测期内的复合年增长率为 7.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
生物反应器市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品类型（一次性、可重复使用）、细胞（哺乳动物细胞、细菌细胞、酵母细胞）、分子（单克隆抗体、疫苗、重组蛋白、干细胞、基因治疗）、用途（实验室规模生产、开发、临床前和临床、商业生产、中试规模生产和全面生产）、规模（5L-20L、20L-200L、200L-1500L 及 1500L 以上）、材料（玻璃、不锈钢和一次性）、控制类型（手动和自动）、供应商（OEM、系统集成商、EPC）、最终用户（研发部门、研发机构、CRO、生物制药公司、生物制药制造商和 CMO） |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), General Electric (U.S.), Eppendorf AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), ZETA (India), PIERRE GUERIN (France), PRaj Hipurity Systems Limited (India), Bioengineering AG (Switzerland), Infors AG (Switzerland), Solaris Biotechnology Srl. (Italy), Bbi Biotech (Germany), Shanghai Bailun Biotechnology co., Ltd. (China), PBS Biotech Inc. (U.S.), CerCell A/S (Denmark), GEA Group Aktiengesellschaft (Germany) |
|
Market Opportunities |
|
Market Definition
A bioreactor is a device that provides a controlled environment for organisms such as animal cells, mammalian cells, yeast cells, and bacteria to grow. They are used in the production of pharmaceuticals such as monoclonal antibodies and vaccines. A controlled environment is required for the manufacture of biological, biochemical, and biomechanically engineered products. A bioreactor is a vessel, tub, or tank that acts as a biological catalyst to aid in the chemical transformation of biological raw materials. Bioreactors have long been used to produce high-value products and therapeutic biomolecules. These instruments regulate and track environmental conditions throughout the culture's ongoing reaction.
Bioreactors Market Dynamics
Drivers
- Broad applications in manufacturing of novel molecules
The growing adoption of advanced technologies to simplify complex manufacturing will drive the market demand. The segmental statistics are expected to be driven by the widespread use of bioreactors in developing and manufacturing complex molecules such as nucleic acids and proteins. These are the certain factors which propel the market growth.
- Initiatives by major corporations
Initiatives by major corporations are also boosting market growth. For instance, Eppendorf's SciVario system for small- and bench-scale applications was introduced in February 2020. The new system is intended for academic and industrial use. Furthermore, in August 2019, the UK-based REPROCELL Europe Ltd announced exclusive distribution rights to the ABLE Biott Bioreactor System. They are a single-use reactor series for stem cell culture. The ABLE Biott Bioreactor System is a lab-scaled bioreactor system that allows stem cell researchers to study and culture pluripotent stem cells in a novel way. These are the initiatives which propel the growth of market.
Opportunities
- Rising R&D activities
Furthermore, growing R&D activities for preventive vaccine development around the world have increased demand for clinical-stage bioreactors. For instance, ABEC has supplied CSR bioreactors to Serum Institute of India Pvt. Ltd. (SIIPL) to manufacture COVID-19 vaccine. As a result of increased adoption of bioreactors in several manufacturing facilities, the market will continue to grow significantly during the forecast period.
Restraints/Challenges
- Lack of availability
The bioreactors market is hampered by a lack of availability and access to various alternative bioreactor methods, as well as a stringent regulatory environment for the system and materials used.
This bioreactors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bioreactors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Merck announced the acquisition of Lonza's MAST platform, an automated aseptic bioreactor sampling system. These platforms assist customers in optimising data during bioprocessing. This acquisition will assist the company in expanding its market presence.
- In 2020, Danaher Corporation acquired General Electric Life Sciences' CYTIVA biopharma business. This strategy has assisted the company in broadening its product offering for biopharma customers and improving market penetration.
Global Bioreactors Market Scope
The bioreactors market is segmented on the basis of product type, cell, molecule, usage, scale, material, control type, suppliers and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Single-use
- Reusable
Cell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
Molecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
Usage
- Lab-Scale Production
- Developmental
- Pre-clinical and Clinical
- Commercial Production
- Pilot-Scale Production
- Full-Scale Production
Scale
- 5L-20L
- 20L-200L
- 200L-1500L
- Above 1500L
Material
- Glass
- Stainless Steel
- Single Use
Control Type
- Manual
- Automated
Suppliers
- OEM
- System Integrators
- EPCs
End User
- Research and Development Departments
- Research and Development Institutes
- CROs
- Biopharmaceutical Companies
- Biopharmaceutical Manufacturer and CMOs
Bioreactors Market Regional Analysis/Insights
对生物反应器市场进行了分析，并按国家、产品类型、细胞、分子、用途、规模、材料、控制类型、供应商和最终用户提供了市场规模见解和趋势。
生物反应器市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于生命科学研究和开发的进步，北美在生物反应器市场占据主导地位。此外，预测期内，投资和生物制造设施数量的增加将推动该地区生物反应器市场的增长。
预计亚太地区将在 2023 年至 2030 年的预测期内以最高的增长率增长，原因是慢性病的增加以及对新型生物药物的需求不断增长，以及制药公司的数量不断增加。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
生物反应器市场还为您提供每个国家/地区资本设备医疗保健支出增长、生物反应器市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对生物反应器市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。
竞争格局和生物反应器市场份额分析
生物反应器市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对生物反应器市场的关注有关。
生物反应器市场的一些主要参与者包括：
- Sartorius AG（德国）
- 赛默飞世尔科技公司（美国）
- 通用电气（美国）
- Eppendorf AG（德国）
- 默克集团（德国）
- Pall 公司 (美国)
- ZETA（印度）
- 皮埃尔·盖兰（法国）
- PRaj Hipurity Systems Limited（印度）
- Bioengineering AG（瑞士）
- Infors AG（瑞士）
- Solaris Biotechnology Srl.（意大利）
- Bbi Biotech（德国）
- 上海百伦生物技术有限公司 (中国)
- PBS Biotech Inc.（美国）
- CerCell A/S（丹麦）
- GEA 集团股份公司（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
